Esperion(ESPR) - 2024 Q3 - Earnings Call Transcript

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q3 2024 Earnings Call November 7, 2024 8:00 AM ET Company Participants Alina Venezia - Director, Investor Relations Sheldon Koenig - President and Chief Executive Officer Ben Halladay - Chief Financial Officer Betty Jean Swartz - Chief Business Officer Eric Warren - Chief Commercial Officer Conference Call Participants Dennis Ding - Jefferies Serge Belanger - Needham Jason Zemansky - Bank of America Lander Egaña-Gorroño - H.C. Wainwright Tom Shrader - BTIG Operator ...